uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
Open Access
- 2 April 2019
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 129 (5) , 1946-1959
Abstract
Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived circulating signaling molecule that has been implicated in chronic kidney disease such as focal segmental glomerulosclerosis (FSGS). Typically, native uPAR (isoform 1) translates to a three-domain protein capable of binding and activating integrins, yet the function of additional isoforms generated by alternative splicing is unknown. Here, we characterized mouse uPAR isoform 2 (msuPAR2), encoding domain I and nearly one-half of domain II, as a dimer in solution, as revealed by 3D electron microscopy structural analysis. In vivo, msuPAR2 transgenic mice exhibited signs of severe renal disease characteristic of FSGS with proteinuria, loss of kidney function and glomerulosclerosis. Sequencing of the glomerular RNAs from msuPAR2-Tg mice revealed differentially expressed gene signature that includes upregulation of the suPAR receptor Itgb3, encoding β3 integrin. Crossing msuPAR2-transgenic mice with three different integrin β3 deficiency models rescued msuPAR2-mediated kidney function. Further analyses indicated a central role for β3 integrin and c-Src in msuPAR2 signaling and in human FSGS kidney biopsies. Administration of Src inhibitors reduced proteinuria in msuPAR2-transgenic mice. In conclusion, mouse uPAR isoform 2 may play an important role in certain forms of scarring kidney disease.Keywords
Funding Information
- NIDDK (1R01 DK101350)
- NIDDK (1R01 DK101350)
This publication has 34 references indexed in Scilit:
- The UCSC Genome Browser database: update 2011Nucleic Acids Research, 2010
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationNature Biotechnology, 2010
- Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its ReceptorJournal of Biological Chemistry, 2010
- Antithrombotic effects of targeting αIIbβ3 signaling in plateletsBlood, 2009
- TopHat: discovering splice junctions with RNA-SeqBioinformatics, 2009
- Src Inhibition Ameliorates Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- EMAN2: An extensible image processing suite for electron microscopyJournal of Structural Biology, 2007
- An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activatorFEBS Letters, 1993
- Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.Journal of Clinical Investigation, 1991